Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

AGC in Race to Bolster CDMO Operations Across US, Europe and Japan

Filed Under: Industry Tagged With: , , , , ,

AGC Inc. (TYO:5201) is gearing up to expand its contract development and manufacturing organization (CDMO) facilities in Japan, the U.S…....

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

AGC Looks to Advance Into Gene and Cell Therapy Business With Tender Offer for MolMed
AGC Looks to Advance Into Gene and Cell Therapy Business…
AGC Plans to Invest Over 200B Yen in CDMO Operations for Gene & Cell Therapy, More
AGC Plans to Invest Over 200B Yen in CDMO Operations for…
Japanese Chemical Companies Find Special Demand for Bio-CDMO Operations Amid COVID-19
Japanese Chemical Companies Find Special Demand for Bio-CDMO…
Sekisui Chemical to Build New Biopharmaceutical Plant in UK
Sekisui Chemical to Build New Biopharmaceutical Plant in UK
Chitose Bio Evolution Moves Forward on Chemical, Bio-CDMO Mass Production in Japan
Chitose Bio Evolution Moves Forward on Chemical, Bio-CDMO…
Japan Looks to Catch the West as Opportunities Open up for mRNA Pharmaceuticals
Japan Looks to Catch the West as Opportunities Open up for…